A Study to Evaluate the Safety and Pharmacokinetics of BX-001N in Healthy Participants

NCT06097702 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Ischemia-reperfusion Injury

Interventions

DRUG: BX-001N Part 1
DRUG: BX-001N Part 2
DRUG: Placebo

Sponsor

Bilix Co.,Ltd.